Clinical trials
Active, not recruiting Phase 2 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chengdu Zenitar Biomedical Technology Co., Ltd | 1 |
| Daiichi Sankyo | 1 |
| National Cancer Institute (NCI) | 1 |
| The First Hospital of Jilin University | 1 |
| The Lymphoma Academic Research Organisation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 5 |
| Recurrence | 2 |
| Autoimmune Diseases | 1 |
| Immune System Diseases | 1 |
| Lymphoma, T-Cell | 1 |
| Lymphoma, T-Cell, Cutaneous | 1 |
| Lymphoproliferative Disorders | 1 |
| Opportunistic Infections | 1 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.